Arya Amini, M.D. | City of Hope

Dr. Arya Amini

Claim this profile

City of Hope Medical Center

Studies Skin Cancer
Studies Lung Cancer
9 reported clinical trials
22 drugs studied

Area of expertise

1Skin Cancer
Arya Amini has run 6 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR positive
2Lung Cancer
Arya Amini has run 6 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
EGFR positive
Stage III

Affiliated Hospitals

Image of trial facility.
City Of Hope Medical Center
Image of trial facility.
City Of Hope Comprehensive Cancer Center

Clinical Trials Arya Amini is currently running

Image of trial facility.

SBRT Guided by PET Scans

for Non-Small Cell Lung Cancer

This phase II trial tests the safety of positron emission tomography (PET) guided stereotactic body radiation therapy (SBRT) and how well it works to treat non-small cell lung cancer (NSCLC), melanoma, and renal cell carcinoma (RCC) that has up to 5 sites of progression (oligoprogression) compared to standard SBRT. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. A PET scan is an imaging test that looks at your tissues and organs using a small amount of a radioactive substance. It also checks for cancer and may help find cancer remaining in areas already treated. Using a PET scan for SBRT planning may help increase the dose of radiation given to the most resistant part of the cancer in patients with oligoprogressive NSCLC, melanoma, and RCC.
Recruiting1 award Phase 212 criteria
Image of trial facility.

Geriatric Assessment

for Lung Cancer

This clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment recommendations, compared to GA with usual care, works in identifying risk factors, reducing chemotherapy radiation toxicity and functional decline, and improving the overall quality of life in older patients with non-small cell lung cancer (NSCLC). Older patients with lung cancer undergoing chemotherapy are at an increased risk of adverse outcomes including treatment toxicity and functional and physical consequences. This makes it very challenging for the physicians to balance the benefits against the risk of chemotherapy in older cancer patients. A geriatric assessment may be useful in identifying risk factors for chemotherapy radiation toxicity. Communicating these geriatric assessment findings and assessment-based recommendations to a patient's treating physicians may help them make more informed decisions about treatment options for patients. Making treatment decisions using GA-based recommendations may reduce adverse events and improve outcomes in patients receiving treatment for NSCLC.
Recruiting1 award N/A10 criteria

More about Arya Amini

Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Arya Amini has experience with
  • Stereotactic Body Radiation Therapy
  • Atezolizumab
  • Carboplatin
  • Biologically Guided Radiation Therapy (BgRT)
  • Osimertinib
  • Stereotactic Body Radiation Therapy (SBRT)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arya Amini specialize in?
Arya Amini focuses on Skin Cancer and Lung Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Arya Amini currently recruiting for clinical trials?
Yes, Arya Amini is currently recruiting for 7 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Arya Amini has studied deeply?
Yes, Arya Amini has studied treatments such as Stereotactic Body Radiation Therapy, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with Arya Amini?
Apply for one of the trials that Arya Amini is conducting.
What is the office address of Arya Amini?
The office of Arya Amini is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.